Massachusetts S797 aims to reduce prescription drug costs by studying a state-run program for generic drug manufacturing.

Massachusetts S797 seeks to lower prescription drug costs by examining the feasibility of a state-run program to manufacture generic or biosimilar drugs. The Health Policy Commission will conduct a study to analyze factors contributing to drug price increases, identify high-spending and high-price-increase drugs, and assess the competitive landscape. The study will also explore the potential impact of such a program on competition, prices, and shortages. The commission must submit a report with findings and recommendations to state officials within a year of the act's passage.

Massachusetts S797 aims to reduce prescription drug costs by studying a state-run program for generic drug manufacturing.

Massachusetts S797 seeks to lower prescription drug costs by examining the feasibility of a state-run program to manufacture generic or biosimilar drugs. The Health Policy Commission will conduct a study to analyze factors contributing to drug price increases, identify high-spending and high-price-increase drugs, and assess the competitive landscape. The study will also explore the potential impact of such a program on competition, prices, and shortages. The commission must submit a report with findings and recommendations to state officials within a year of the act's passage.